The U.S. Food and Drug Administration (FDA) has revised the label for the Merck & Co. manufactured male baldness drug Propecia to include warnings of sexual side effects that may continue even after stopping treatment. The new label was announced after a review of existing studies found a link between finasteride, the active ingredient in Propecia, and numerous sexual problems including orgasm disorders, erectile dysfunction and loss of libido. The new label also warns of reports of male infertility and poor semen quality, however these problems were found to normalize after patients discontinued use of the drug.
If you or a loved one has developed sexual problems as a result of taking Propecia, you may be entitled to compensation for your damages. To find out if you qualify for a reward, fill out our free, no-risk case review form today.
The FDA decided to update the Propecia label after a critical number of reports were made to Merck & Co. detailing sexual side effects that persisted even after patients stopped treatment. The earlier labeling acknowledged the possibility of sexual problems, but claimed any irregularities were reversible and would cease after the patient discontinued use of the drug. According to the most recent Propecia study, sexual side effects brought on by finasteride vary on a patient by patient basis, but can potentially last up to three months or, in the worst cases, indefinitely.
There have already been a number of Propecia lawsuits filed against Merck & Co. alleging that the pharmaceutical giant failed to properly warn of the sexual side effects caused by its drug. Persons who have suffered sexual dysfunction as a result of taking Propecia may be entitled to monetary compensation for damages including, but not necessarily limited to, medical bills, emotional distress and pain and suffering. To learn if you qualify for a Propecia lawsuit, complete our free, no hassle case evaluation today.